SRPT
SAREPTA THERAPEU
Health Care·Biotechnology·UNITED STATES
$19.22
MCap $2B
as of 2026-08-20
Total
C1w
Fund
C9w
Quant
D1w
Price
▲ Up▼ Down━ MA30━ MA100━ Mean┄ U┄ L
MIDOS % pane · green > 90 long zone · red < 10 short zone · reference lines at 10 / 90
MIDOS SI
as of 2026-08-20
MIDOS SI
-0.15
Sentiment 68.9%
−3 oversold0+3 overbought
Signal
NEUTRAL
Actual
$19.22
Adaptive Mean
$19.34
-0.12 vs mean
Adaptive σ
0.39
MIDOS BB
$18.55 – $20.13
center ± 2σ adaptive
Fundamental Factors (Sector-Relative Z)
as of 2026-08-06
Composite Z
+0.34
ROE
4.9%
Z +0.16
Rev Gr
-1.9%
Z -0.32
EPS Gr
—
Z +0.03
OPM Gr
89.4%
Z +1.16
FCF Yld
11.6%
Z +0.46
EPS Surp
0.3%
Z +0.98
EPS 3mo Δ
465.9%
Z -0.08
Fwd P/E
7.47
Z —
PEGY
N/A
growth + yield ≤ 0
Momentum (Risk-Adjusted Alpha)
as of 2026-08-21
Q3M
5.39
Q6M
0.10
Q12M
-0.44
MA 30/100
0.926
Bearish (MA30 < MA100)
α (Jensen)
0.5232
β (12M)
2.04
σ (12M)
0.803
Momentum inflection: Q3M > Q12M
Divergence — Fundamentals vs Momentum
Z Percentile
87%
Q Percentile
40%
Divergence
+47.0
Tier
RELOAD — WATCH
Fundamentals well ahead of momentum. Strong reload candidate when momentum inflects.
Kirkpatrick RS & Persistence
RS
-4.1
RS Pctl
55%
RS Decile
D6
Persistence
1w
at grade C
Options / OI Analysis
No options or Williams data available for this ticker.